|
1
|
Ferlay J, Autier P, Boniol M, Heanue M,
Colombet M and Boyle P: Estimates of the cancer incidence and
mortality in Europe in 2006. Ann Oncol. 18:581–592. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Manfredi S, Lepage C, Hatem C, Coatmeur O,
Faivre J and Bouvier AM: Epidemiology and management of liver
metastases from colorectal cancer. Ann Surg. 244:254–259. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Poston GJ, Figueras J, Giuliante F, Nuzzo
G, Sobrero AF, Gigot JF, Nordlinger B, Adam R, Gruenberger T, Choti
MA, et al: Urgent need for a new staging system in advanced
colorectal cancer. J Clin Oncol. 26:4828–4833. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Witke W, Li W, Kwiatkowski DJ and
Southwick FS: Comparisons of CapG and gelsolin-null macrophages:
Demonstration of a unique role for CapG in receptor-mediated
ruffling, phagocytosis and vesicle rocketing. J Cell Biol.
154:775–784. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dahl E, Sadr-Nabavi A, Klopocki E, Betz B,
Grube S, Kreutzfeld R, Himmelfarb M, An HX, Gelling S, Klaman I, et
al: Systematic identification and molecular characterization of
genes differentially expressed in breast and ovarian cancer. J
Pathol. 205:21–28. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Harpaz N and Saxena R: Modern surgical
pathologyGastrointestinal Tract, Large Intestine. Weidner N, Cote
RJ, Suster S and Weiss LM: 1. 1st. Saunders, Philadelphia: pp.
749–852. 2003
|
|
7
|
Weber A, Kristiansen I, Johannsen M,
Oelrich B, Scholmann K, Gunia S, May M, Meyer HA, Behnke S, Moch H
and Kristiansen G: The FUSE binding proteins FBP1 and FBP3 are
potential c-myc regulators in renal, but not in prostate and
bladder cancer. BMC Cancer. 8:3692008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harrison S and Benziger H: The molecular
biology of colorectal carcinoma and its implications: A review.
Surgeon. 9:200–210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miyoshi N, Ohue M, Shingai T, Noura S,
Sugimura K, Akita H, Gotoh K, Motoori M, Takahashi H, Kishi K, et
al: Clinicopathological characteristics and prognosis of stage IV
colorectal cancer. Mol Clin Oncol. 3:1093–1098. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gau DM, Lesnock JL, Hood BL, Bhargava R,
Sun M, Darcy K, Luthra S, Chandran U, Conrads TP, Edwards RP, et
al: BRCA1 deficiency in ovarian cancer is associated with
alteration in expression of several key regulators of cell
motility-A proteomics study. Cell Cycle. 14:1884–1892. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kobayashi M, Nagashio R, Ryuge S, Murakami
Y, Yanagita K, Nakashima H, Matsumoto T, Jiang SX, Saegusa M, Satoh
Y, et al: Acquisition of useful sero-diagnostic autoantibodies
using the same patients'sera and tumor tissues. Biomed Res.
35:133–143. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morelli M, Scumaci D, Di Cello A,
Venturella R, Donato G, Faniello MC, Quaresima B, Cuda G, Zullo F
and Costanzo F: DJ-1 in endometrial cancer: A possible biomarker to
improve differential diagnosis between subtypes. Int J Gynecol
Cancer. 24:649–658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Da Costa GG, Gomig TH, Kaviski R, Sousa
Santos K, Kukolj C, De Lima RS, De Andrade Urban C, Cavalli IJ and
Ribeiro EM: Comparative proteomics of tumor and paired normal
breast tissue highlights potential biomarkers in breast cancer.
Cancer Genomics Proteomics. 12:251–261. 2015.PubMed/NCBI
|
|
14
|
Renz M and Langowski J: Dynamics of the
CapG actin-binding protein in the cell nucleus studied by FRAP and
FCS. Chromosome Res. 16:427–437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ichikawa H, Kanda T, Kosugi S, Kawachi Y,
Sasaki H, Wakai T and Kondo T: Laser microdissection and
two-dimensional difference gel electrophoresis reveal the role of a
novel macrophage-capping protein in lymph node metastasis in
gastric cancer. J Proteome Res. 12:3780–3791. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Glaser J, Neumann MH, Mei Q, Betz B, Seier
N, Beyer I, Fehm T, Neubauer H, Niederacher D and Fleisch MC:
Macrophage capping protein CapG is a putative oncogene involved in
migration and invasiveness in ovarian carcinoma. Biomed Res Int.
2014:3798472014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kimura K, Ojima H, Kubota D, Sakumoto M,
Nakamura Y, Tomonaga T, Kosuge T and Kondo T: Proteomic
identification of the macrophage-capping protein as a protein
contributing to the malignant features of hepatocellular carcinoma.
J Proteomics. 78:362–373. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nomura H, Uzawa K, Ishigami T, Kouzu Y,
Koike H, Ogawara K, Siiba M, Bukawa H, Yokoe H, Kubosawa H and
Tanzawa H: Clinical significance of gelsolin-like actin-capping
protein expression in oral carcinogenesis: An immunohistochemical
study of premalignant and malignant lesions of the oral cavity. BMC
Cancer. 8:392008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thompson CC, Ashcroft FJ, Patel S, Saraga
G, Vimalachandran D, Prime W, Campbell F, Dodson A, Jenkins RE,
Lemoine NR, et al: Pancreatic cancer cells overexpress gelsolin
family-capping proteins, which contribute to their cell motility.
Gut. 56:95–1067. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ouellet V, Provencher DM, Maugard CM, Le
Page C, Ren F, Lussier C, Novak J, Ge B, Hudson TJ, Tonin PN and
Mes-Masson AM: Discrimination between serous low malignant
potential and invasive epithelial ovarian tumors using molecular
profiling. Oncogene. 24:4672–4687. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Partheen K, Levan K, Osterberg L, Claesson
I, Fallenius G, Sundfeldt K and Horvath G: Four potential
biomarkers as prognostic factors in stage III serous ovarian
adenocarcinomas. Int J Cancer. 123:2130–2137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang F, Li C, Liu H, Wang Y, Chen Y and
Wu X: The functional proteomics analysis of VEGF-treated human
epithelial ovarian cancer cells. Tumour Biol. 35:12379–12387. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kang S, Kim MJ, An H, Kim BG, Choi YP,
Kang KS, Gao MQ, Park H, Na HJ, Kim HK, et al: Proteomic molecular
portrait of interface zone in breast cancer. J Proteome Res.
9:5638–5645. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li MX, Xiao ZQ, Chen YH, Peng F, Li C,
Zhang PF, Li MY, Li F, Duan CJ, Li DJ, et al: Proteomic analysis of
the stroma-related proteins in nasopharyngeal carcinoma and normal
nasopharyngeal epithelial tissues. Med Oncol. 27:134–144. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu WY, Hunag YY, Liu XG, He JY, Chen DD,
Zeng F, Zhou JH and Zhang YK: Prognostic evaluation of CapG,
gelsolin, P-gp, GSTP1, and Topo-II proteins in non-small cell lung
cancer. Anat Rec (Hoboken). 295:208–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Morofuji N, Ojima H, Onaya H, Okusaka T,
Shimada K, Sakamoto Y, Esaki M, Nara S, Kosuge T, Asahina D, et al:
Macrophage-capping protein as a tissue biomarker for prediction of
response to gemcitabine treatment and prognosis in
cholangiocarcinoma. J Proteomics. 75:1577–1589. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Komuro K, Tada M, Tamoto E, Kawakami A,
Matsunaga A, Teramoto K, Shindoh G, Takada M, Murakawa K, Kanai M,
et al: Right- and left-sided colorectal cancers display distinct
expression profiles and the anatomical stratification allows a high
accuracy prediction of lymph node metastasis. J Surg Res.
124:216–224. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Konopke R, Distler M, Ludwig S and
Kersting S: Location of liver metastases reflects the site of the
primary colorectal carcinoma. Scand J Gastroenterol. 43:192–195.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kang B, Hao C, Wang H, Zhang J, Xing R,
Shao J, Li W, Xu N, Lu Y and Liu S: Evaluation of
hepatic-metastasis risk of colorectal cancer upon the protein
signature of PI3K/AKT pathway. J Proteome Res. 7:3507–3515. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Watari A, Takaki K, Higashiyama S, Li Y,
Satomi Y, Takao T, Tanemura A, Yamaguchi Y, Katayama I, Shimakage
M, et al: Suppression of tumorigenicity, but not anchorage
independence, of human cancer cells by new candidate tumor
suppressor gene CapG. Oncogene. 25:7373–7380. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
De Corte V, Van Impe K, Bruyneel E,
Boucherie C, Mareel M, Vandekerckhove J and Gettemans J: Increased
importin-beta-dependent nuclear import of the actin modulating
protein CapG promotes cell invasion. J Cell Sci. 117:5283–5292.
2004. View Article : Google Scholar : PubMed/NCBI
|
